CFDE Data Portal | Search MIR99AHG

	Label	Description
	MIR99AHG Gene (Entity type)	ENSG00000215386 - mir-99a-let-7c cluster host gene
	MIR99AHG associations Collection (Entity type)	Associations for MIR99AHG_associations
	MIR99AHG associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE113655 phenol 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE238213 dopamine 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE199538 GSE199539 enzalutamide 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE150540 dipyridamole DPM HUVEC-C 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE183535 MYC inhibition HeLa 0 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE56010 adenosine 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 8 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

MIR99AHG

ENSG00000215386 - mir-99a-let-7c cluster host gene

MIR99AHG associations

Associations for MIR99AHG_associations

MIR99AHG associations.tsv

A file from IDG as part of the Harmonizome project

GSE113655 phenol 1 v 2 human dn

A Gene Set from LINCS

GSE238213 dopamine 2 v 0 human up

A Gene Set from LINCS

GSE199538 GSE199539 enzalutamide 2 v 1 human dn

A Gene Set from LINCS

GSE150540 dipyridamole DPM HUVEC-C 1 v 2 human up

A Gene Set from LINCS

GSE183535 MYC inhibition HeLa 0 v 6 human dn

A Gene Set from LINCS

GSE56010 adenosine 4 v 1 human dn

A Gene Set from LINCS

GSE239844 crizotinib 8 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.